United Services Automobile Association Regeneron Pharmaceuticals, Inc. Transaction History

United Services Automobile Association

  • $2.95 Billion
  • Q4 2024

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 13, 2019
SELL
$273.46 - $318.39 $58.3 Million - $67.8 Million
-213,034 Closed
0 $0
Q2 2019

Aug 16, 2019
SELL
$299.6 - $414.82 $1.95 Million - $2.7 Million
-6,498 Reduced 2.96%
213,034 $66.7 Million
Q1 2019

May 13, 2019
BUY
$372.08 - $439.57 $5.9 Million - $6.97 Million
15,857 Added 7.79%
219,532 $90.1 Million
Q4 2018

Feb 13, 2019
SELL
$335.82 - $403.04 $2.13 Million - $2.56 Million
-6,341 Reduced 3.02%
203,675 $76.1 Million
Q3 2018

Nov 13, 2018
SELL
$351.14 - $408.51 $7.91 Million - $9.21 Million
-22,539 Reduced 9.69%
210,016 $84.9 Million
Q2 2018

Sep 27, 2018
SELL
$284.6 - $344.99 $193 Million - $234 Million
-677,687 Reduced 74.45%
232,555 $80.2 Million
Q2 2018

Aug 10, 2018
BUY
$284.6 - $344.99 $198 Million - $240 Million
696,573 Added 326.01%
910,242 $39.7 Million
Q1 2018

May 14, 2018
BUY
$315.82 - $393.78 $12.6 Million - $15.8 Million
40,025 Added 23.05%
213,669 $73.6 Million
Q4 2017

Feb 14, 2018
BUY
$358.63 - $469.95 $4.44 Million - $5.81 Million
12,367 Added 7.67%
173,644 $65.3 Million
Q3 2017

Nov 14, 2017
BUY
$431.38 - $504.0 $69.6 Million - $81.3 Million
161,277
161,277 $72.1 Million

Others Institutions Holding REGN

# of Institutions
1,487
Shares Held
85.7M
Call Options Held
1.53M
Put Options Held
1.43M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.5B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track United Services Automobile Association Portfolio

Follow United Services Automobile Association and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of United Services Automobile Association, based on Form 13F filings with the SEC.

News

Stay updated on United Services Automobile Association with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email